Pulse Biosciences (PLSE) Total Non-Current Liabilities (2016 - 2026)
Pulse Biosciences (PLSE) posted quarterly Total Non-Current Liabilities of $13.9 million for Q4 2025, down 21.11% year-over-year from $17.6 million in Q4 2024, and down 13.61% quarter-over-quarter from $16.1 million in Q3 2025.
Pulse Biosciences (PLSE) Total Non-Current Liabilities (2016 - 2026) Analysis & Trends
Pulse Biosciences' Total Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $13.9 million for Q4 2025.
- In Q4 2025, Total Non-Current Liabilities fell 21.11% year-over-year to $13.9 million; the TTM figure through Dec 2025 stood at $13.9 million (down 21.11% YoY), while the FY2025 annual figure was $13.9 million, down 21.11% from the prior year.
- Total Non-Current Liabilities for Q4 2025 stood at $13.9 million, down from $16.1 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $81.4 million in Q3 2022, with the low at $13.8 million in Q3 2023.
- The 5-year median for Total Non-Current Liabilities is $17.2 million (2022), against an average of $30.3 million.
- The sharpest annual moves came in 2021 and 2023: Total Non-Current Liabilities jumped 497.24% in 2021, then tumbled 83.04% in 2023.
- Pulse Biosciences' Total Non-Current Liabilities stood at $14.8 million in 2021, then soared by 441.6% to $80.1 million in 2022, then sank by 81.54% to $14.8 million in 2023, then rose by 18.95% to $17.6 million in 2024, then fell by 21.11% to $13.9 million in 2025.
- Business Quant data shows PLSE's Total Non-Current Liabilities at $13.9 million in Q4 2025, $16.1 million in Q3 2025, and $15.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Pulse Biosciences | 3.50 Bn | 3.50 Bn | 161,000.00 | 16.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.06 Mn |
| Dec 31, 2025 | 13.88 Mn |
| Sep 30, 2025 | 16.07 Mn |
| Jun 30, 2025 | 15.76 Mn |
| Mar 31, 2025 | 14.93 Mn |
| Dec 31, 2024 | 17.60 Mn |
| Dec 31, 2023 | 14.79 Mn |
| Sep 30, 2023 | 13.80 Mn |
| Jun 30, 2023 | 14.26 Mn |
| Mar 31, 2023 | 80.89 Mn |
| Dec 31, 2022 | 80.13 Mn |
| Sep 30, 2022 | 81.38 Mn |
| Jun 30, 2022 | 17.18 Mn |
| Mar 31, 2022 | 18.74 Mn |
| Dec 31, 2021 | 14.79 Mn |
| Sep 30, 2021 | 19.76 Mn |
| Jun 30, 2021 | 20.29 Mn |
| Mar 31, 2021 | 60.16 Mn |
| Dec 31, 2020 | 18.40 Mn |
| Sep 30, 2020 | 16.99 Mn |